<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201108049305N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-12-13</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Psoas myofascial release in nonspecific low back pain</public_title>
      <acronym></acronym>
      <scientific_title>Comparison between the effect of routine physiotherapy and routine physiotherapy with Psoas muscle direct myofascial release technique on pain and disability index in patient with chronic nonspecific low back pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-11-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/52220</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study simple randomization is used. For generating random sequence, table of random numbers generated by Start Trek website is used, there are 40 numbers in this table which are coding from 01 to 40. After writing the numbers by the researcher, she will read the randomized number from left to right, so the first 20 codes will be in the control group and the second 20 codes will be in the intervention group. Based on the time of attending, the participants will be coded from 01, 02, ..., 40 till the sample size being completed, Blinding description: This is a single blinded study. The assessor (who going to assess the outcome measures and collect the data) will be blind. Each participant will be aware of treatment that is being used for her/him. The researcher(physiotherapist) is aware of each participant's sort of treatment. 
The person who prepares the article draft and Data Safety and Monitoring Committee, will not be aware of each participant's grouping.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Nonspecific chronic low back pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention is Psoas muscle myofascial release technique, This technique is going to be done as following: In supine position with 90 degree  hip and knees. Therapist puts her hands on Psoas muscle for 3 min and then will perform transvers sliding. In the intervention group, in addition to this technique, routine physiotherapy is performed (consist of 20min electrotherapy, 5min Ultrasound, 10 min hot pack, exercise therapy). Patients will receive 8 sessions of routine physiotherapy in 3 weeks (3 sessions per week) and 4 sessions of myofascial release therapy (in sessions 1, 3, 5, 7). Intervention 2: Control group: Participants in the control group will receive routine physiotherapy in 8 sessions (consist of 20min electrotherapy, 5min Ultrasound, 10 min hot pack, exercise therapy).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data obtained, including information on the main outcomes and individual characteristics of the participants (including height, weight, body mass index and gender) will be published as an article without identifying the participant. If needed, individual information will be shared with other researchers and the Data Safety and Monitoring Committee.

When:
Access period starts 6 months after the results are published

To whom:
Researchers working in academic and scientific institutions can apply for information.

Conditions:
Other researchers can be used to collect data or write systematic reviews, to guide and improve the quality of patients' treatment and encourage similar studies.

Where to obtain:
Applicants should contact the general manager of this research to obtain documentation and data. For this purpose, contact Kosar Iranpour at 00989217104152, email address K.iranpour75@gmail.com and postal code 81799-37531. Address: No. 12, Lale Ally, Farabi2 Ave, Ghadir Blvd, Sepahanshahr Town, Isfahan.

How to obtain:
After 6 months from the publication of the results of the study, individuals who have a certificate from academic institutions can apply for data and documents and receive the documents about 1 to 2 months later.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Kosar Iranpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 12, Lale alley, Farabi 2 Ave, Ghadir Blvd, Sepahanshahr</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81799-37531</zip>
        <telephone>+98 31 3650 2472</telephone>
        <email>k.iranpour75@rehab.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Kosar Iranpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 12, Lale alley, Farabi 2 Ave, Ghadir Blvd, Sepahanshahr</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81799-37531</zip>
        <telephone>0098 31 6502472</telephone>
        <email>K.iranpour75@rehab.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>18_60 years old patient with diagnosed nonspecific chronic low back pain
Pain in lumbar region, at least since 3 months ago
Score 3_7 in Visual Analog Scale
Disability index score of 4_8 in Roland‐Morris disability questionnaire
Having enough literacy for filling the questionnaire
Having at least two parameters of tree following conditions:
- Positive modified Thomas test, at least in one side of pelvic
- Tenderness due to pressure on Psoas muscle, at least in one side of pelvic
- Producing pain and uncomfortable due to Psoas muscle maximum contraction, at least in one side of pelvic</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnancy
BMI score more than 30
History of lumbar spine surgery
Low back pain due to serious spinal pathology such as tumor, infection, inflammatory disorders
Symptoms of disc herniation (reduction of lower extremity force, reduction of reflexes of lower extremity, positive Straight Leg Raise test in less than 45 degrees.
No pain reduction in rest, No pain increasing with activity
History of fracture in spinal region
History of recent trauma to spine
Pain in resting
Joint disorders such as Rheumatoid Arthritis
Lumbar vertebral Spondylolisthesis
Using paregoric and muscle relaxant medicine in past 48 hours before assessment
Fibromyalgia
History of myofascial or rehabilitation treatment in past 2 months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Low back pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention is Psoas muscle myofascial release technique, This technique is going to be done as following: In supine position with 90 degree  hip and knees. Therapist puts her hands on Psoas muscle for 3 min and then will perform transvers sliding. In the intervention group, in addition to this technique, routine physiotherapy is performed (consist of 20min electrotherapy, 5min Ultrasound, 10 min hot pack, exercise therapy). Patients will receive 8 sessions of routine physiotherapy in 3 weeks (3 sessions per week) and 4 sessions of myofascial release therapy (in sessions 1, 3, 5, 7).</i_keyword>
      <i_keyword>Control group: Participants in the control group will receive routine physiotherapy in 8 sessions (consist of 20min electrotherapy, 5min Ultrasound, 10 min hot pack, exercise therapy).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain score. Timepoint: Before starting the treatment, 1day and 4 weeks after the end of treatment. Method of measurement: Visual Analog Scale.</prim_outcome>
      <prim_outcome>Disability index. Timepoint: Before starting the treatment, 1day and 4 weeks after the end of treatment. Method of measurement: Roland‐Morris Disability Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-09-26</approval_date>
        <contact_name>Ethics committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Building No. 4, Isfahan University of Medical Sciences, Hezar Jarib Ave, Isfahan Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
